REMEGEN (09995) Sets 27 Mar 2026 Board Meeting to Review FY2025 Results and Dividend Proposal

Bulletin Express
03/17

REMEGEN Co., Ltd. (09995) has scheduled a board meeting for 27 March 2026. Directors will review and approve the consolidated financial results for the year ended 31 December 2025 and consider a dividend distribution, if any.\n\nThe meeting notice was signed by Chairman and Executive Director Mr. Wang Weidong on 17 March 2026 in Yantai, PRC.\n\nBoard composition at the announcement date:\n• Executive Directors: Mr. Wang Weidong, Dr. Fang Jianmin, Mr. Wen Qingkai, Mr. Lin Jian\n• Non-Executive Directors: Dr. Wang Liqiang, Dr. Su Xiaodi\n• Independent Non-Executive Directors: Mr. Hao Xianjing, Mr. Chen Yunjin, Mr. Huang Guobin

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10